Odyssey Therapeutics Announces $218 Million Series A Financi

Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines

/PRNewswire/ -- Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced the...

Related Keywords

Boston , Massachusetts , United States , Harvard University , Joseph Mcdonald , Carll Gordon , Carl Gordon , Charles Baum , Jill Carroll , Stephen Soisson , Bristol Myers Squibb , Davidl Pompliano , Natalie Dales , Shifeng Pan , Valerie Odegard , Robert Abraham , Garyd Glick , Damon Runyon Walter Winchell Cancer Research , Genomics Institute Of The Novartis Research Foundation , Novartis , Pfizer , Chemistry At Harvard University , University Of Pittsburgh , Rockefeller University , Computational Chemistry At Carnegie Mellon University , Johns Hopkins School Of Medicine , York University , Mcdonald , Structural Protein Sciences At Merck Research Laboratories , Molecular Biology At Harvard University , Columbia University , Roswell Park Memorial Institute , Millennium Pharmaceuticals , University Of Wisconsin , Stanford University , Orbimed Advisors , Capital Management , Foresite Capital , Woodline Partners , Logos Capital , Colt Ventures , Creacion Ventures , Managing Partner , Chief Executive Officer , Norganic Chemistry , Executive Vice President , Cancer Biology , Chief Scientific Officer , Vividion Therapeutics , Senior Vice President , Group Head , Oncology Rd Group , Pfizer Worldwide Research , Drug Discovery , Executive Director , Global Discovery Chemistry Group , Novartis Genesis Labs , Chief Data Officer , Physics Based Simulation , Avila Therapeutics , Computational Chemistry , Carnegie Mellon , Discovery Chemistry , Genomics Institute , Novartis Research Foundation , New York University , Chief Innovation Officer , Revolution Medicines , Lodo Therapeutics , Worldwide Basic Head , Infectious Diseases , Vice President , Molecular Biology , Structural Biology , Protein Therapeutics , Global Head , Structural Chemistry , Structural Protein Sciences , Merck Research Laboratories , Johns Hopkins School , Odyssey Therapeutics , Mirati Therapeutics ,

© 2025 Vimarsana